Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05607966Recruiting

A Post-market Observational ORIGIN® CR Clinical Study

Role: lead

NCT06628050Active Not Recruiting

ORIGIN® PS Modular & Associated Instruments

Role: lead

NCT04728542Recruiting

ORIGIN® vs. VANGUARD® PS Observational Study

Role: lead

NCT06628336Recruiting

Post-Market Observational Study of the HARMONY® Evolution Implants and Instruments

Role: lead

NCT05120063Not ApplicableActive Not Recruiting

Benefit of 3-D Planning in Total Hip Replacement. A Prospective Randomized Study

Role: collaborator

All 5 trials loaded